nodes	percent_of_prediction	percent_of_DWPC	metapath
Acamprosate—GRIN2C—CREB phosphorylation through the activation of CaMKII—CAMK2B—osteoarthritis	0.0353	0.0353	CbGpPWpGaD
Acamprosate—GRIN2C—Unblocking of NMDA receptor, glutamate binding and activation—CAMK2B—osteoarthritis	0.0353	0.0353	CbGpPWpGaD
Acamprosate—GRM5—Hypothetical Network for Drug Addiction—CAMK2B—osteoarthritis	0.0332	0.0332	CbGpPWpGaD
Acamprosate—GRIN2D—CREB phosphorylation through the activation of CaMKII—CAMK2B—osteoarthritis	0.0328	0.0328	CbGpPWpGaD
Acamprosate—GRIN2D—Unblocking of NMDA receptor, glutamate binding and activation—CAMK2B—osteoarthritis	0.0328	0.0328	CbGpPWpGaD
Acamprosate—GRIN2C—Ras activation uopn Ca2+ infux through NMDA receptor—CAMK2B—osteoarthritis	0.0323	0.0323	CbGpPWpGaD
Acamprosate—GRIN2D—Ras activation uopn Ca2+ infux through NMDA receptor—CAMK2B—osteoarthritis	0.03	0.03	CbGpPWpGaD
Acamprosate—GRIN2A—Unblocking of NMDA receptor, glutamate binding and activation—CAMK2B—osteoarthritis	0.0269	0.0269	CbGpPWpGaD
Acamprosate—GRIN2A—CREB phosphorylation through the activation of CaMKII—CAMK2B—osteoarthritis	0.0269	0.0269	CbGpPWpGaD
Acamprosate—GRIN2A—Ras activation uopn Ca2+ infux through NMDA receptor—CAMK2B—osteoarthritis	0.0246	0.0246	CbGpPWpGaD
Acamprosate—GRIN1—Unblocking of NMDA receptor, glutamate binding and activation—CAMK2B—osteoarthritis	0.0235	0.0235	CbGpPWpGaD
Acamprosate—GRIN1—CREB phosphorylation through the activation of CaMKII—CAMK2B—osteoarthritis	0.0235	0.0235	CbGpPWpGaD
Acamprosate—GRIN2C—CREB phosphorylation through the activation of Ras—CAMK2B—osteoarthritis	0.023	0.023	CbGpPWpGaD
Acamprosate—GRIN2B—Unblocking of NMDA receptor, glutamate binding and activation—CAMK2B—osteoarthritis	0.0229	0.0229	CbGpPWpGaD
Acamprosate—GRIN2B—CREB phosphorylation through the activation of CaMKII—CAMK2B—osteoarthritis	0.0229	0.0229	CbGpPWpGaD
Acamprosate—GRIN1—Ras activation uopn Ca2+ infux through NMDA receptor—CAMK2B—osteoarthritis	0.0215	0.0215	CbGpPWpGaD
Acamprosate—GRIN2D—CREB phosphorylation through the activation of Ras—CAMK2B—osteoarthritis	0.0214	0.0214	CbGpPWpGaD
Acamprosate—GRIN2C—Hypothetical Network for Drug Addiction—CAMK2B—osteoarthritis	0.0213	0.0213	CbGpPWpGaD
Acamprosate—GRIN2B—Ras activation uopn Ca2+ infux through NMDA receptor—CAMK2B—osteoarthritis	0.0209	0.0209	CbGpPWpGaD
Acamprosate—GRIN2D—Hypothetical Network for Drug Addiction—CAMK2B—osteoarthritis	0.0198	0.0198	CbGpPWpGaD
Acamprosate—GRIN2C—Post NMDA receptor activation events—CAMK2B—osteoarthritis	0.0189	0.0189	CbGpPWpGaD
Acamprosate—GRIN2D—Post NMDA receptor activation events—CAMK2B—osteoarthritis	0.0176	0.0176	CbGpPWpGaD
Acamprosate—GRIN2A—CREB phosphorylation through the activation of Ras—CAMK2B—osteoarthritis	0.0176	0.0176	CbGpPWpGaD
Acamprosate—GRIN2C—Activation of NMDA receptor upon glutamate binding and postsynaptic events—CAMK2B—osteoarthritis	0.0174	0.0174	CbGpPWpGaD
Acamprosate—GRIN2A—Hypothetical Network for Drug Addiction—CAMK2B—osteoarthritis	0.0162	0.0162	CbGpPWpGaD
Acamprosate—GRIN2D—Activation of NMDA receptor upon glutamate binding and postsynaptic events—CAMK2B—osteoarthritis	0.0162	0.0162	CbGpPWpGaD
Acamprosate—GRIN1—CREB phosphorylation through the activation of Ras—CAMK2B—osteoarthritis	0.0153	0.0153	CbGpPWpGaD
Acamprosate—GRIN2B—CREB phosphorylation through the activation of Ras—CAMK2B—osteoarthritis	0.0149	0.0149	CbGpPWpGaD
Acamprosate—GRIN2A—Post NMDA receptor activation events—CAMK2B—osteoarthritis	0.0145	0.0145	CbGpPWpGaD
Acamprosate—GRIN1—Hypothetical Network for Drug Addiction—CAMK2B—osteoarthritis	0.0142	0.0142	CbGpPWpGaD
Acamprosate—GRIN2B—Hypothetical Network for Drug Addiction—CAMK2B—osteoarthritis	0.0138	0.0138	CbGpPWpGaD
Acamprosate—GRIN2A—Activation of NMDA receptor upon glutamate binding and postsynaptic events—CAMK2B—osteoarthritis	0.0133	0.0133	CbGpPWpGaD
Acamprosate—GRIN1—Post NMDA receptor activation events—CAMK2B—osteoarthritis	0.0126	0.0126	CbGpPWpGaD
Acamprosate—GRIN2B—Post NMDA receptor activation events—CAMK2B—osteoarthritis	0.0123	0.0123	CbGpPWpGaD
Acamprosate—GRIN1—Activation of NMDA receptor upon glutamate binding and postsynaptic events—CAMK2B—osteoarthritis	0.0116	0.0116	CbGpPWpGaD
Acamprosate—GRIN2B—Activation of NMDA receptor upon glutamate binding and postsynaptic events—CAMK2B—osteoarthritis	0.0113	0.0113	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—SOX9—osteoarthritis	0.00974	0.00974	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—IHH—osteoarthritis	0.00711	0.00711	CbGpPWpGaD
Acamprosate—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2B—osteoarthritis	0.00653	0.00653	CbGpPWpGaD
Acamprosate—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2B—osteoarthritis	0.00607	0.00607	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—COL2A1—osteoarthritis	0.00516	0.00516	CbGpPWpGaD
Acamprosate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2B—osteoarthritis	0.00498	0.00498	CbGpPWpGaD
Acamprosate—GRIN2C—Transmission across Chemical Synapses—CAMK2B—osteoarthritis	0.00491	0.00491	CbGpPWpGaD
Acamprosate—GRIN2D—Transmission across Chemical Synapses—CAMK2B—osteoarthritis	0.00456	0.00456	CbGpPWpGaD
Acamprosate—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2B—osteoarthritis	0.00435	0.00435	CbGpPWpGaD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—osteoarthritis	0.00427	0.00427	CbGpPWpGaD
Acamprosate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2B—osteoarthritis	0.00424	0.00424	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—MCF2L—osteoarthritis	0.00402	0.00402	CbGpPWpGaD
Acamprosate—GRIN2C—Neuronal System—CAMK2B—osteoarthritis	0.00376	0.00376	CbGpPWpGaD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—CAMK2B—osteoarthritis	0.00375	0.00375	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IHH—osteoarthritis	0.00365	0.00365	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—MCF2L—osteoarthritis	0.00365	0.00365	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—BMP2—osteoarthritis	0.00361	0.00361	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—BMP2—osteoarthritis	0.00352	0.00352	CbGpPWpGaD
Acamprosate—GRIN2D—Neuronal System—CAMK2B—osteoarthritis	0.0035	0.0035	CbGpPWpGaD
Acamprosate—GRIN1—Transmission across Chemical Synapses—CAMK2B—osteoarthritis	0.00327	0.00327	CbGpPWpGaD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—CAMK2B—osteoarthritis	0.00319	0.00319	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—IL1RN—osteoarthritis	0.00309	0.00309	CbGpPWpGaD
Acamprosate—GRIN2C—Alzheimers Disease—IL1B—osteoarthritis	0.003	0.003	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—CAMK2B—osteoarthritis	0.00287	0.00287	CbGpPWpGaD
Acamprosate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2B—osteoarthritis	0.00287	0.00287	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—COL9A2—osteoarthritis	0.00284	0.00284	CbGpPWpGaD
Acamprosate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2B—osteoarthritis	0.00282	0.00282	CbGpPWpGaD
Acamprosate—GRIN2D—Alzheimers Disease—IL1B—osteoarthritis	0.00279	0.00279	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—IL1A—osteoarthritis	0.00278	0.00278	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—COL9A2—osteoarthritis	0.00277	0.00277	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—COL9A1—osteoarthritis	0.00276	0.00276	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—COL9A1—osteoarthritis	0.00269	0.00269	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—CAMK2B—osteoarthritis	0.0025	0.0025	CbGpPWpGaD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2B—osteoarthritis	0.00246	0.00246	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—CAMK2B—osteoarthritis	0.00244	0.00244	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—BMP2—osteoarthritis	0.00238	0.00238	CbGpPWpGaD
Acamprosate—GRIN2A—Alzheimers Disease—IL1B—osteoarthritis	0.00229	0.00229	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—LEP—osteoarthritis	0.00227	0.00227	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—IL1A—osteoarthritis	0.00222	0.00222	CbGpPWpGaD
Acamprosate—GRIN1—EPH-Ephrin signaling—MMP2—osteoarthritis	0.00218	0.00218	CbGpPWpGaD
Acamprosate—GRIN2C—Alzheimers Disease—TNF—osteoarthritis	0.00218	0.00218	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—CAMK2B—osteoarthritis	0.00216	0.00216	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MCF2L—osteoarthritis	0.00216	0.00216	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IHH—osteoarthritis	0.00216	0.00216	CbGpPWpGaD
Acamprosate—GRIN2B—EPH-Ephrin signaling—MMP2—osteoarthritis	0.00212	0.00212	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—CAMK2B—osteoarthritis	0.00212	0.00212	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—COL9A2—osteoarthritis	0.00203	0.00203	CbGpPWpGaD
Acamprosate—GRIN2D—Alzheimers Disease—TNF—osteoarthritis	0.00202	0.00202	CbGpPWpGaD
Acamprosate—GRIN1—Alzheimers Disease—IL1B—osteoarthritis	0.002	0.002	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—COL9A2—osteoarthritis	0.00197	0.00197	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—COL9A1—osteoarthritis	0.00197	0.00197	CbGpPWpGaD
Acamprosate—GRIN2B—Alzheimers Disease—IL1B—osteoarthritis	0.00195	0.00195	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—COL9A1—osteoarthritis	0.00192	0.00192	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—CAMK2B—osteoarthritis	0.00185	0.00185	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL1RN—osteoarthritis	0.00175	0.00175	CbGpPWpGaD
Acamprosate—GRIN2A—Alzheimers Disease—TNF—osteoarthritis	0.00166	0.00166	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—CAMK2B—osteoarthritis	0.00165	0.00165	CbGpPWpGaD
Acamprosate—GRIN1—EPH-Ephrin signaling—MMP9—osteoarthritis	0.00164	0.00164	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—CAMK2B—osteoarthritis	0.00162	0.00162	CbGpPWpGaD
Acamprosate—GRIN2B—EPH-Ephrin signaling—MMP9—osteoarthritis	0.0016	0.0016	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—COL9A2—osteoarthritis	0.00158	0.00158	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—PTGS2—osteoarthritis	0.00156	0.00156	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—COL9A1—osteoarthritis	0.00154	0.00154	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—CXCL8—osteoarthritis	0.00151	0.00151	CbGpPWpGaD
Acamprosate—GRIN1—Alzheimers Disease—TNF—osteoarthritis	0.00145	0.00145	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—IL1B—osteoarthritis	0.00145	0.00145	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—CAMK2B—osteoarthritis	0.00142	0.00142	CbGpPWpGaD
Acamprosate—GRIN2B—Alzheimers Disease—TNF—osteoarthritis	0.00141	0.00141	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—MMP9—osteoarthritis	0.00137	0.00137	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL1A—osteoarthritis	0.00126	0.00126	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—CXCL8—osteoarthritis	0.00124	0.00124	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—MMP3—osteoarthritis	0.00123	0.00123	CbGpPWpGaD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoarthritis	0.00123	0.00123	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—CXCL8—osteoarthritis	0.00121	0.00121	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—IL1B—osteoarthritis	0.00116	0.00116	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—TGFB1—osteoarthritis	0.00113	0.00113	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—BMP2—osteoarthritis	0.00105	0.00105	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—TNF—osteoarthritis	0.00105	0.00105	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—IL6—osteoarthritis	0.000848	0.000848	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—SMAD3—osteoarthritis	0.000846	0.000846	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—TNF—osteoarthritis	0.000841	0.000841	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—SMAD3—osteoarthritis	0.000824	0.000824	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—MMP2—osteoarthritis	0.00081	0.00081	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—MMP2—osteoarthritis	0.00079	0.00079	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MMP3—osteoarthritis	0.000729	0.000729	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—LEP—osteoarthritis	0.000723	0.000723	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—LEP—osteoarthritis	0.000705	0.000705	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—CXCL8—osteoarthritis	0.000699	0.000699	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—CXCL8—osteoarthritis	0.000684	0.000684	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—IL6—osteoarthritis	0.000678	0.000678	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—SMAD3—osteoarthritis	0.00066	0.00066	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL1B—osteoarthritis	0.000656	0.000656	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CXCL8—osteoarthritis	0.000635	0.000635	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—MMP9—osteoarthritis	0.000609	0.000609	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—MMP9—osteoarthritis	0.000593	0.000593	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MMP2—osteoarthritis	0.000578	0.000578	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—LEP—osteoarthritis	0.000564	0.000564	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MMP2—osteoarthritis	0.000563	0.000563	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ESR1—osteoarthritis	0.000539	0.000539	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—FN1—osteoarthritis	0.000532	0.000532	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—TNF—osteoarthritis	0.000476	0.000476	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IGF1—osteoarthritis	0.000466	0.000466	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MMP9—osteoarthritis	0.000434	0.000434	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MMP9—osteoarthritis	0.000423	0.000423	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL6—osteoarthritis	0.000384	0.000384	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—IL6—osteoarthritis	0.000378	0.000378	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CXCL8—osteoarthritis	0.000375	0.000375	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—IL6—osteoarthritis	0.000369	0.000369	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—TGFB1—osteoarthritis	0.000358	0.000358	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL6—osteoarthritis	0.000357	0.000357	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—TGFB1—osteoarthritis	0.000349	0.000349	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MMP9—osteoarthritis	0.000339	0.000339	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—TNF—osteoarthritis	0.000334	0.000334	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—TNF—osteoarthritis	0.000326	0.000326	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TGFB1—osteoarthritis	0.00028	0.00028	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—IL6—osteoarthritis	0.00027	0.00027	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—IL6—osteoarthritis	0.000263	0.000263	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL6—osteoarthritis	0.000211	0.000211	CbGpPWpGaD
